From the 4C
"Key business development activities during the quarter included the strengthening of our relationships with State Governments for the supply of EuGeni tests once TGA approved and, importantly, the renewal of the Ellume contract for the ongoing supply of AnteoBind for a further five years."
Ann: Quarterly Update / Appendix 4C, page-103
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.73M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 650000 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 111493 | 3 |
View Market Depth
| Last trade - 16.24pm 17/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable